Finance & Investment

GoldenTree's oversubscribed $3B fund close highlights a major shift as institutional investors seek flexible, high-yield private credit strategies.

The South American retail giant repurchased a massive slice of its 2027 debt, a move analysts see as a bold play to extend maturities and fuel growth.

Artemis Gold overcomes an unexpected shutdown at its new Blackwater Mine, posting record gold recovery and reaffirming its ambitious expansion plans.

Cookeville wealth firm Cravens & Company Advisors hires a CFA charterholder as Director of Investments and promotes an analyst in a strategic expansion.

Ress Life Investments reports a 1.7% NAV gain but sheds $84M in assets, pivoting to an earnout model. What does this mean for the life settlement market?

With tax refunds up 10%, experts offer a roadmap to turn that cash into real wealth, from debt reduction to hedging with gold. Here's how.

Skeena Resources is raising $750M to slash a gold stream obligation and fully fund its path to production, a strategic bet on its high-grade Eskay Creek mine.

A new partnership tokenizes a fund holding SpaceX and OpenAI shares, making elite private market investments accessible onchain for the first time globally.

With a massive capital injection from a convertible note offering, i-80 Gold is fast-tracking its plan to become a major Nevada gold producer.

The L.A.-based bank extends its $300M stock repurchase program and will redeem $385M in notes, a move analysts see as a confident financial play.

Amidst financial pressures and a major restructuring, Verde Clean Fuels appoints its CFO as CEO to explore strategic options, including a potential sale.

Junior explorer BULGOLD aims to advance its Lutila Gold Project with a new private placement, signaling confidence in its Central European gold strategy.

Two Toledo auto shop sales highlight why investors are flocking to necessity-based real estate, driven by stable income and powerful tax incentives.

With promising clinical data for its lead drug silevertinib and a strong new financial position, Black Diamond Therapeutics charts a dual course for two deadly cancers.

As traditional income sources falter, Obra Capital's structured products ETF is booming. But do the high yields justify the complex risks involved?

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.

The Southern Michigan bank's dividend hike and capital strategy highlight its financial health and commitment to shareholders amid a dynamic regional economy.

The nation's largest landscaper affirms its financial health by paying an $8.8M cash dividend, avoiding share dilution and signaling confidence to investors.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

After a massive stock drop, ODDITY Tech signals confidence with an expanded $200M share buyback. Is it a sign of value or a maturing growth story?